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In this paper, we have shown for the fi rst time the soft tissue response of  novel silver/
poly(vinyl alcohol)/graphene (Ag/PVA/Gr) and silver/poly(vinyl alcohol)/chitosan/
graphene (Ag/PVA/CHI/Gr) nanocomposite hydrogels aimed for medical applications. 
These novel hydrogels were produced by in situ electrochemical synthesis of  silver 
nanoparticles in the polymer matrices as described in our previously published works. 
Both Ag/PVA/Gr and Ag/PVA/CHI/Gr, as well as controls Ag/PVA, Ag/PVA/CHI 
and commercial Suprasorb© hydrogel discs, were implanted in the subcutaneous tissue 
of  rats. Implants with the surrounding tissue were dissected after post-implantation 
on days 7, 15, 30 and 60, and then processed for histological examination. The tissue 
irritation index (TIrI) score, according to ISO 10993-6, 2007, as well as the number 
of  leukocytes in the peri-implant zone and connective tissue capsule thickness were 
examined. The results show that each TIrI score, the leukocyte number around the 
implanted materials and capsule thickness gradually decreased during the observation 
period. At the endpoint of  follow-up, the Ag/PVA/CHI/Gr implant was surrounded 
with a thinner capsule, while both the TIrI score and the number of  leukocytes of  
the peri-implant zone were greater compared to the Ag/PVA/Gr implant. Despite the 
observed differences, we can conclude that our in vivo experiment suggested that both 
novel hydrogels were biocompatible and suitable for medical use.
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INTRODUCTION
Regenerative medicine is a domain of  great interest for medical researchers. The 
successful application of  a medical device or implant depends on the properties of  the 
biomaterials used to fabricate the device or implant, as well as on various other factors, 
including the manufacturing and processing of  the implant materials, and the specifi c 
application in which the device is used [1]. Synthetic or natural polymers are a common 
base of  such materials, because of  their resemblance to real tissue. Hydrogels based 
on natural or synthetic polymers and their blends, are generally used for biomedical 
purposes. Their biocompatibility, hydrophilicity, and processability enable a wide range 
of  applications.
Poly(vinyl alcohol) (PVA) is a synthetic polymer, which is commonly used in the 
preparation of  biocomposites for various applications, such as wound dressings [2,3] 
and scaffolds for tissue engineering [4-6] due to its biocompatibility and non-toxicity. 
Due to their exceptional hydrophilicity, with many –OH groups on the side chain, 
PVA hydrogels are able to swell in aqueous solutions. This is particularly important for 
wound dressing applications, as the wound surroundings need to be kept moist at all 
times, and the hydrogel with a high water content can provide moisture and facilitate the 
removal of  the dressing without damaging the wound tissue [7]. In addition, hydrogels 
are well suitable for tissue engineering applications, as their structure resembles that 
of  soft tissue, and the porous matrices provide the appropriate environment for cell 
adhesion and tissue ingrowth [8,9]. A potential use of  toxic cross linkers could also be 
eliminated by preparation of  PVA hydrogels with a simple freezing-thawing method 
[10,11]. 
Chitosan is a natural linear polysaccharide with a polycationic nature, comprised of  
β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine units. It is obtained by 
partial or complete deacetylation of  chitin, most commonly derived from crustaceans 
or fungi [12]. Due to the excellent biocompatibility and biodegradability, as well as to 
its natural antibacterial properties, chitosan has been used in various branches of  tissue 
engineering and biomedicine [12,13]. Some examples of  chitosan applications include 
wound dressings [14-17], tissue engineering [18,19], scaffolds or coatings for bone 
tissue implants [20-22] and drug delivery [23-25]. 
As a result of  their unique properties, such as the antimicrobial activity against many 
microorganisms, silver nanoparticles (AgNPs) are especially attractive for use in 
medical applications [26,27]. AgNPs, however, tend to agglomerate due to their high 
surface energy, which leads to weakening of  their antibacterial properties. This is why 
polymer-based stabilizers are frequently applied in order to lower their surface energy 
and to immobilize AgNPs in the polymer matrix. PVA is a polymer with many –OH 
groups on its chain that can act as binding sites for AgNPs and thus contribute to their 
stability inside the hydrogel [28]. Chitosan contains both –OH and –NH2 groups that 
allow binding to AgNPs and their further stabilization in the porous hydrogel matrix 
[29,30].
Lužajić Božinovski et al.: In vivo investigation of  soft tissue response of  novel silver/poly(vinyl alcohol)/ graphene and silver/poly(vinyl alcohol)/chitosan/graphene hydrogels aimed for medical applications – the fi rst experience
323
Graphene (Gr) is a recently discovered material that has found frequent usage in 
biomedical applications [27,28]. Graphene is a two-dimensional (2D) monolayer of  
carbon atoms, stacked in a honeycomb lattice and this unique structure provides it 
with exceptional properties, such as high mechanical strength and great electrical 
and thermal conductivity [31,32]. All these properties could provide reinforcement 
to the polymeric materials, so graphene is often included in a polymer matrix as a 
nano-fi ller. The overall mechanical properties of  the hydrogel matrices were shown 
to be improved by even small amounts of  graphene in PVA/Gr hydrogels [33-35]. 
There is also a recent interest in the potential antibacterial activity of  graphene [36], 
which could be benefi cial for wound dressing or soft tissue implant applications, as 
these properties could provide additional bactericidal effects together with AgNPs, 
especially in the early phases of  application to prevent biofi lm formation. However, 
the antibacterial properties and specifi cally the mechanism of  action is still debatable 
and somewhat controversial and more research, both in vitro and in vivo,is needed in 
this area of  graphene application.
The aim of  this study was to examine the impact of  the incorporated graphene on the 
specifi c characteristics of  Ag/PVA and Ag/PVA/CHI nanocomposite hydrogels, as 
well as to examine the local response of  the subcutaneous tissue after implementation 
of  novel Ag/PVA/Gr and Ag/PVA/CHI/Gr implants.
MATERIALS AND METHODS
Material
For the preparation and synthesis of  nanocomposite hydrogels, the following chemicals 
were utilized: chitosan (CHI) powder (medium Mw, Sigma Aldrich, St. Louis, MO, 
USA), poly(vinyl alcohol) (PVA) powder (fully hydrolyzed, Mw = 70–100 kDa; Sigma 
Aldrich, St. Louis, MO, USA), graphene (Gr) nanopowder (Graphene Supermarket, 
Calverton, NY, USA), silver nitrate (M. P. Hemija, Belgrade, Serbia), potassium nitrate 
(Centrohem d.o.o., Stara Pazova, Serbia), glacial acetic acid (Betahem d.o.o., Belgrade, 
Serbia). Ultra-pure water (Milli-Q system, Millipore, Burlington, MA, USA) was used 
in all experiments.
Preparation of PVA, PVA/Gr, PVA/CHI and PVA/CHI/Gr hydrogels
PVA and PVA/Gr hydrogels were prepared according to the procedure published 
elsewhere [37-39]. PVA/CHI and PVA/CHI/Gr hydrogels were obtained following 
similar procedure [30].
Electrochemical synthesis of Ag/PVA, Ag/PVA/Gr, Ag/PVA/CHI and Ag/
PVA/CHI/Gr nanocomposite hydrogels
For the synthesis of  silver nanoparticles (AgNPs), the PVA, PVA/Gr, PVA/CHI 
and PVA/CHI/Gr hydrogels were cut into discs with an approximate diameter of  
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5 mm and width of  2 mm (appropriate dimensions for in vivo experiments). Before 
the electrochemical synthesis, the discs were immersed in 0.25 mM AgNO3 swelling 
dispersions, with 0.1 M KNO3 added to ensure better electrical conductivity. The 
containers with hydrogel discs in swelling dispersions were kept at 48 h in a dark place, 
to achieve the equilibrium swelling of  the samples. In situ electrochemical synthesis of  
AgNPs was performed by electrochemical reduction of  Ag+ ions at constant voltage 
inside the PVA, PVA/Gr, PVA/CHI and PVA/CHI/Gr polymer matrices. A custom 
made glass electrochemical cell was used, with two horizontal Pt plates as working and 
counter electrodes, between which the hydrogel samples were placed in a sandwich-like 
setup. The MA 8903 Electro-Phoresis Power Supply (Iskra d.d., Ljubljana, Slovenia) 
was used for the electrochemical synthesis. The synthesis was carried out at 90 V with 
implementation time of  4 min, and the polarity of  the electrodes was reversed every 1 
min. Before and after every experiment, the electrodes were cleaned with HNO3 (1:1) 
and distilled water.
In vivo experiment
Sterilized Ag/PVA, Ag/PVA/Gr, Ag/PVA/CHI and Ag/PVA/CHI/Gr nano-
composite hydrogel discs, as well as commercial Suprasorb©, a calcium alginate dressing 
(Lohmann & Rauscher GmbH & Co. KG, Neuwied, Germany) were implanted in the 
subcutaneous tissue of  16 anesthetized adult females. A small skin incision on the rat 
back, at the level of  the midline of  the thoracic spinal column, was made to create 
fi ve pockets in the subcutis of  back lateral sides, which distanced 3 cm from the back 
midline. The pockets were directed cervically and lumbally, so the distance between 
implanted material areas was about 3 to 3.5 cm (Fig. 1A) the implants were introduced 
through the pockets. A surgical incision made on the right lateral side opposite of  
the Suprasorb© implantation represented the control area. The experiment lasted 60 
days. Surgical implantation of  hydrogels was done according to the permeation of  the 
Ethical Committee of  the Faculty of  Veterinary Medicine, University of  Belgrade.
Figure 1. The appearance of  Ag/PVA/Gr and Ag/PVA/CHI/Gr implants during surgical 
intervention, immediately after implantation (A) and at postimplantation day 60 (B). Black 
and white arrows indicate Ag/PVA/Gr and Ag/PVA/CHI/Gr respectively, at both presented 
periods (A and B).
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All animals survived the surgery. No wound healing complications were observed 
after the surgery and during the whole experiment. The experimental materials were 
retrieved from the rats after post-implantation day (p.i.d.) 7, 15, 30 and 60, and there 
were thus four subgroups of  animals corresponding to the different periods, i.e. each 
subgroup consisted of  four animals. After the endpoint of  the above mentioned 
experimental periods, the animals were sacrifi ced and implants with the surrounding 
tissue were dissected, fi xed, and processed by conventional procedures for histological 
examination. At each end point of  the experiment, including postoperative day 60, the 
distance between implants corresponded to that of  implantation time, and we did not 
notice that implant come close to each other or were joining (Fig. 1B).
Histological examination
Tissue processing for light microscopy
Tissue paraplast blocks were serially sectioned stained with Hematoxylin-Eosin (H&E) 
and Van Gieson staining protocols, and then were evaluated under a light microscope. 
However, for histomorphometry, only sections with the largest length and width 
diameters of  the implanted discs were collected.
Morphological examination
In order to estimate the processes of  tissue response, regeneration and the tissue-
implant interface, the obtained slides were examined semiquantitatively by following 
histological reactions: epithelial alterations, relative number of  infl ammatory cells, 
vascular congestion, edema, and the presence and connective tissue capsule thickness. 
All these parameters were presented as the tissue irritation index (TIrI) score, according 
to the ISO 10993-6, 2007. The TIrI was as follows: the value of  1 to 5, 6 to 10, 11 
to 15, and 16 to 20 indicates minimal, mild, moderate and severe tissue responses, 
respectively.
Histomorphometry
Morphometric methods included: 1) counting the number of  infl ammatory cells in 
the peri-implanted area and 2) measuring the capsule thickness. The capsule thickness 
was measured with an ocular micrometer, at x 100 magnifi cation. The total capsule 
thickness from four sides (upper-lower-right-left) was measured, and the mean value 
of  these measurements was obtained. The number of  infl ammatory cells of  the peri-
implant area was counted in fi ve representative zones of  each specimen, by using 
ocular grids which consist of  a square limiting test area of  0,250 mm2, at magnifi cation 
of  40x. The results were expressed as the number of  infl ammatory cells per mm2 of  
profi le area. All sections were examined using standard Olympus BX-41 microscope 
and archived with Olympus XC50 digital camera, using the CellSens Entry software 
(Olympus, Tokyo, Japan).
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Statistical analysis
The data were analyzed in the statistical software package IBM SPSS 20. Analysis of  
variance for repeated measurements was performed within the general linear model. 
All results are expressed as mean ± SE. The minimum level of  statistical signifi cance 
was set at p <0.05.
RESULTS
Soft tissue response – general observation during
the post-implantation period for all implanted hydrogels
Total irritation index score
Semiquantitative evaluation of  the local soft tissue reaction (i.e. TIrI score) to the 
subcutaneously implanted Ag/PVA, Ag/PVA/Gr, Ag/PVA/CHI, Ag/PVA/CHI/
Gr and Suprasorb© hydrogels, as well as tissue reaction at pseudooperated regions 
(incision skin) is shown in Fig. 2.
Firstly, there was not strong tissue response to different implanted materials in any 
of  the observed periods, and necrosis of  surrounded peri-implant tissue was not 
observed. Secondly, the results show that the TIrI scores, after the type of  hydrogels 
applied, in each observation period were between the minimal and mild value limits, 
except for the p.i.d. 7 in the case of  implanted Ag/PVA, the p.i.d. 7 and 15 in the case 
of  implanted Ag/PVA/CHI, and p.i.d. 30 in the case of  implanted Ag/PVA/CHI/
Gr, when registering moderate tissue reactions. Thirdly, at the end of  the observed 
period, the tissue response to the implanted materials was minimal or mild. Finally, 
Figure 2. TIrI score for all examined implanted biomaterials and control area of  skin incision. 
***p<0.001 relative to Ag/PVA; a – p<0.001 relative to Suprasorb; b – p<0.01 relative to Ag/
PVA/CHI; c – p<0.001 relative to Ag/PVA/CHI; d – p< 0.001 relative to Pseudooperated 
region; e – p<0.001 relative to Ag/PVA/CHI/Gr; f  – p<0.001 relative to all other observed 
periods; g – p<0.001 relative to 60 days; h – p<0.001 relative to 30 days; i – p<0.01 relative to 
60 days.
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at the end of  the observation period, the smallest TIrI was recorded in the case of  
implanted Ag/PVA and Ag/PVA/Gr hydrogels, and these values did not differ from 
the control values. Ag/PVA/CHI/Gr was the only material which had signifi cantly 
higher values of  TIrI scores at the end of  the observation period compared to the 
implanted materials, including Suprasorb© or the control pseudooperated region.
Leukocyte infi ltration
The leukocyte number around the implanted materials was the highest at p.i.d. 7 
compared to all other periods (p<0.001) and gradually decreased during the observation 
period, with a certain deviation in the case of  implanted Ag/PVA/CHI/Gr. In addition, 
in all observed periods, there were signifi cantly higher leukocyte numbers around each 
of  the implanted materials compared to the implanted Suprasorb© (p<0.01), with the 
exception on p.i.d. 60, when no signifi cant differences were recorded between the 
Suprasorb© and Ag/PVA hydrogels. In addition, it can be noted that implantations 
of  the hydrogels in each observed period caused a lower infl ammatory response in 
comparison to incision surgery (p<0.01), with the exception of  Ag/PVA/CHI/Gr 
implant at p.i.d. 60, when the number of  leukocytes was signifi cantly higher (p<0.001) 
(Fig. 3).
Connective tissue capsule
During the fi rst weeks after surgery, the site of  implantation was embedded with a 
connective tissue capsule in a similar way for each of  the implanted materials, and 
thus isolated from the surrounding tissues. A progressive increase of  connective tissue 
capsule thickness around each implanted material was observed from day 7 to day 30, 
but after that the thickness of  the capsule decreased over time and fi nally, at p.i.d. 60, 
it reached the mean dimensions between 33+2.39 and 70+2.68 mm for implanted 
Suprasorb© and Ag/PVA/Gr, respectively. The capsule thickness in all examined 
Figure 3. Leukocytic infi ltration of  the peri-implant zone for all examined biomaterials 
and control area of  skin incision. ***p<0.001 relative to Suprasorb; a – p<0.001 relative to 
Pseudooperated region; b – p<0.001 relative to  Ag/PVA; c – p<0.001 relative to  Ag/PVA/
CHI/Gr; d – p<0.001 relative to all other observed periods; e – p<0.001 relative to 7 days; f  – 
p<0.001 relative to 30 days; g – p<0.05 relative to 60 days.
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periods after implantation was the highest in the case of  implanted Ag/PVA/Gr. 
During the observation period, the thinnest capsules around Ag/PVA/CHI were at 
the 30th day after surgery, as well as surrounding Ag/PVA/CHI and Suprasorb© on 
the 60th day after surgery (Fig. 4).
Both macrophages and giant cells were seen in the connective tissue capsule 
surrounding each implanted material in any examined period.
Tissue reaction in the case of implantations of Ag/PVA versus Ag/PVA/Gr
Ag/PVA implantation induced the strongest tissue response at p.i.d. 7 (TIrI 13+0.26), 
and it was signifi cantly higher in relation to all observed periods, as well as with 
Figure 4. Tissue capsule thickness (dash) around implanted A – Ag/PVA/Gr and B – Ag/
PVA/CHI/Gr hydrogels (star) at postimplantation day 60. The pictures show that Ag/PVA/
CHI/ Gr implant was surrounded with a thinner capsule than Ag/PVA/Gr implant. H&E, bar: 
100 µm; C – Connective tissue capsule thickness for all implanted biomaterials. ***p<0.001 
relative to Ag/PVA; a – p<0.01 relative to Ag/PVA/CHI/Gr; b – p<0.001 relative to Ag/
PVA/Gr; c – p<0.001 relative to Ag/PVA/CHI/Gr; d – p<0.05 relative to Suprasorb; e – 
p<0.001 relative to Suprasorb; f  – p<0.01 relative to Ag/PVA/Gr; g – p<0.001 relative to 7 
days; h – p<0.001 relative to 60 days; i – p<0.01 relative to 60 days.
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comparison to all other implanted hydrogels or pseudooperated regions (p<0.001). 
However, after this, the tissue response to Ag/PVA progressively decreased up to p.i.d. 
60, where TIrI score (5.00+0.35) had a minimal level and similar value to Suprasorb© 
and the pseudooperated region.
In contrast, monitoring of  the tissue response dynamic during the Ag/PVA/Gr 
implantation demonstrated that this biomaterial caused induction a far smaller tissue 
response at p.i.d. 7 compared to implanted Ag/PVA. Also, the degree of  tissue 
response to this biomaterial was unchanged during the fi rst 30 days, but signifi cantly 
higher (p<0.001) than the value observed at p.i.d. 60. Specifi cally, at p.i.d. 60, TIrI 
in the case of  Ag/PVA/Gr hydrogels was similar to both Ag/PVA and Suprasorb© 
implantations as well as the control pseudooperated region (Fig. 2).
However, there was a higher leukocyte number in the peri-implant area surrounding 
Ag/PVA/Gr than Ag/PVA at both p.i.d. 30 and 60 (p<0,001) (Fig. 3). Similarly, 
throughout the monitoring period, there was a signifi cantly thicker capsule surrounding 
the implanted Ag/PVA/Gr compared to Ag/PVA (p<0.001) (Fig. 4).
Tissue reaction in the case of implantations of
Ag/PVA/CHI versus Ag/PVA/CHI/Gr
Ag/PVA/CHI implantation induced the strongest tissue response at p.i.d. 15, while 
in the case of  Ag/PVA/CHI/Gr implantation this response was somewhat delayed 
and strongest at p.i.d. 30. After these observed peaks, there were signifi cantly reduced 
tissue reactions at the end of  the observed period for both implanted materials, and 
the degree of  reduction was signifi cant compared to each previous observation period 
(p<0.001). However, at p.i.d. 30 and 60, TIrI scores in the cases of  implanted Ag/
PVA/CHI/Gr were signifi cantly higher in comparison with the control values, as well 
as in relation to implanted Ag/PVA/CHI (p<0.001) (Fig. 2).
Leukocyte infi ltration of  the peri-implant zone was gradually decreased during the entire 
monitoring period in the case of  implanted Ag/PVA/CHI (p<0.001). However, in the 
case of  implanted Ag/PVA/CHI/Gr there was an increase in leukocyte infi ltration 
at p.i.d. 60. Also, although this increase was signifi cant in relation to the previous 
study period (p<0.001), the leukocyte number was signifi cantly lower compared to the 
highest values observed at p.i.d. 7 (p<0.001) (Fig. 3).
The thickness of  the capsule was signifi cantly increased during the fi rst 30 days after 
implantation (p<0.001; p.i.d. 30: p.i.d. day 7), and then was decreased at p.i.d. 60, in 
cases of  both implanted Ag/PVA/CHI or Ag/PVA/CHI/Gr. Although the thickness 
of  the capsule around the implanted Ag/PVA/CHI/Gr was signifi cantly higher 
compared to the implanted Ag/PVA/CHI at p.i.d. 30 (p<0.001), this difference was 
lost at p.i.d. 60. However, the thickness of  the capsules of  both implanted materials 
remained signifi cantly higher in relation to the capsule surrounding the implanted 
Suprasorb© (p<0.001), and signifi cantly higher than the initial values at p.i.d. 7 
(p<0.001) (Fig. 4).
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Ag/PVA/Gr versus Ag/PVA/CHI/Gr - in vivo soft tissue response differences 
after implantation of these novel hydrogels
According to TIrI score, the tissue response was far more strong at p.i.d. 60 in the 
case of  implanted Ag/PVA/CHI/Gr in comparison to implanted Ag/PVA/Gr 
(p<0.001) (Fig. 2). A similar situation exists with regard to the degree of  leukocyte 
infi ltration. (Fig. 3). However, the Ag/PVA/CHI/Gr implant was surrounded with 
a thinner capsule than Ag/PVA/Gr during all examined periods, and this difference 
is statistically signifi cant at both the beginning and the end points of  the follow-up 
period (p<0.01) (Fig. 4).
Degradation of implanted hydrogels
Macrophages penetrated all implanted hydrogels at the beginning of  the monitoring 
period, and they were observed both in the periphery and the deeper zones of  
implanted materials during follow-up (Fig. 5). There are vacuoles with phagocytosed 
materials in the cytoplasm of  these macrophages.
Figure 5. Implanted Ag/PVA/CHI/Gr resorption by giant cells or macrophages (arrows) 
activities during follow-up period. H&E, bar: 20 µm. A – 7 days, B – 15 days, C – 30 days, 
D – 60 days.
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DISCUSSION
In this study, we investigated the biocompatibility of  novel polymers based on PVA 
or PVA/CHI hydrogels with silver nanoparticles (AgNPs), in which graphene was 
incorporated to improve their properties. There are several studies of  Ag/PVA/Gr 
[33,40−43], and Ag/PVA/CHI/Gr polymers [30,39,44], however, none provides 
information regarding their in vivo biocompatibility. For this reason, our in vivo 
investigations of  novel Ag/PVA/Gr and Ag/PVA/CHI/Gr hydrogels with improved 
physical properties should be the basis for further preclinical and clinical research with 
the goal of  their application in human and veterinary medicine.
Given the small amounts of  the gelling agent and the high content of  liquids (up to 
99%), the hydrogels have a density close to water density, but possess the structural 
bonding of  a solid substance. Polymeric hydrogels may be natural (including chitosan) 
or synthetic (including PVA) [45].
The simple structure and unique properties of  PVA polymers such as adhesion, 
strength, fi lm formation, hydrophilicity but very low swelling capacity (due to their 
sensitivity to hydrogen bonding and over-crystallization), biocompatibility, safety and 
non-cancerous properties, make them desirable for specifi c biomedical applications 
[46]. To date, many uses of  PVA hydrogels have been proposed in biomedicine, 
including their use as soft materials for building contact lenses [47], artifi cial cornea 
[48], artifi cial cartilage and meniscus [49,50], tendon and bone regeneration [51,52], 
hydrogel coating of  the humeral head surface in shoulder joint prosthesis [53], for 
suppressing the formation of  adhesions in peritonitis [54], vehicle for medicaments, 
including prolonged release of  antibiotics in veterinary medicine [55,56], cell growth 
substrate [57], for prostate brachytherapy preparations [58], cardiovascular grafts [59], 
and other. It is necessary to look with great optimism at the results of  the fi rst clinical 
study with long-term follow-up (5-8 years) of  the commercial PVA (Cortiva, RTI 
Surgical Inc., FL, USA) implant success in focal cartilage defects. These results showed 
that synthetic PVA hydrogel implants guarantee functional recovery of  a knee joint in 
mid-life patients with focal lesions of  the cartilage [60]. The fi rst preliminary results of  
a clinical study on repairing the human joint surface metacarpal bone by implantation 
of  PVA in patients with osteoarthritis were published [61]. Also, excellent clinical 
results fi ve years after PVA hydrogel hemiarthroplasty of  the fi rst metatarso-phalangeal 
joint in advanced hallux rigidus were obtained [62].
However, physical properties of  PVA hydrogels are generally reversible which disrupts 
their stability [45]. The viscosity, the degree of  crystallization and pH sensitivity of  
PVA cryogels changes over time, which leads to poor mechanical properties. Also, 
in comparison with other hydrogels, PVA hydrogels weakly adsorbed the proteins 
resulting in low cell adhesion, which, in the opinion of  some authors, makes them 
less effective in the treatment of  cartilage defects by the matrix-associated autologous 
chondrocyte transplantation [63].
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Therefore, many PVA copolimers have been synthesized up to now. PVA (50%) and 
silk fi broin (50%) copolymer hydrogel was successfully used in tissue engineering 
of  auricular cartilage, so further preclinical research with this new biomaterial is 
expected [64]. Thus, important for the context of  this paper is that PVA copolymers 
with graphene [40] chitosan [65, 66], graphene and chitosan [44] are also described. 
Initial studies of  the biocompatibility of  porous PVA/chitosan hydrogel composite 
designed for tissue engineering scaffold showed that this material has no toxicity, but 
after muscle implantation, there was a stronger infl ammatory reaction on the 4th week, 
compared with porous PVA/nano-hydroxyapatite or porous PVA [67]. However, 
one recent study has shown that PVA/chitosan composite hydrogel can be used as a 
carrier for mesenchymal stem cells during focal cartilage defect therapy [65]. In novel 
nanocomposites based on chitosan-polyvinyl alcohol (CHI-PVA) and graphene oxide 
(GO), GO reinforced CHI-PVA engineering [40,44].
PVA is one of  the most frequently and the oldest synthetic polymer employed as 
wound dressings. However, PVA hydrogel has inadequate elasticity, a stiff  membrane, 
a relatively poor barrier property to bacterial penetration, sometimes poor mechanical 
stability and incomplete hydrophilic characteristics which restrict its use alone as a 
wound dressing polymeric membrane. Among the various hydrogels described in 
literature, hydrogels prepared using PVA blended with some natural polysaccharides 
and some other synthetic ones, including chitosan, graphene and Ag nanoparticles 
(AgNPs), are attractive and the most widespread route of  membranes synthesis, because 
of  the abundance of  such polymers, easy for chemical derivatization or modifi cation, 
and usually good biocompatible propreties [68]. However, these nanomaterials may 
potentially be risky for human health. Therefore, it is necessary to thoroughly examine 
their biocompatibility under in vivo conditions.
The introduction of  AgNPs into polymer/copolymer hydrogels increases their 
antimicrobial activity, and the incorporation of  graphene increases their mechanical 
properties. These materials are not biodegradable, so their use is recommended for 
surface wound treatment or as soft tissue implants. It was found that out of  all metals 
with antimicrobial properties, silver had the most effective antibacterial action and 
lowest toxicity to animal cells [68]. However, the potential toxic effects of  AgNPs 
on the circulatory, respiratory, central nervous system, liver and skin should not be 
forgotten. There is an increased trend for reduced usage of  antibiotics in both humans 
and animals, as well as antibiotics in animal production. Numerous studies on the 
properties and possibilities of  the application of  the hybrid PVA/AgNPs material 
[55,69], proved its advantages for topical therapeutic use in the experimental creamy 
formula with silver, suitable for recovery of  the microbial homeostasis in animals.
Graphene-based composite hydrogels, in which graphene is produced from graphene 
oxide, exhibit antibacterial activity particularly against Gram-negative bacteria [38]. 
Additionally, the presence of  AgNPs in composite hydrogels with graphene accelerates 
the rate of  wound healing in animal models [70]. Recently, the novel PVA/graphene 
oxide/starch/Ag polymer nanocomposite fi lm was successfully produced for 
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biomedical use [43]. Incorporation of  GO nanoparticles into PVA/starch/Ag fi lms 
signifi cantly increased the antimicrobial activity of  fi lms according to Gram-positive 
and negative bacteria. Contrary, some work suggests possible direct toxic effects of  
oxidized graphene to human osteoblasts [71] and respiratory system, i.e. exacerbation 
of  allergic asthma [72]. However, a combination of  GO with PVA reduces both the 
proliferation delay and the internal cell complexity alterations induced by GO on 
human osteoblasts, increases both cell viability and IL-6 levels, reducing both apoptosis 
and intracellular ROS content when compared to simple blending of  both materials. 
The use of  this strategy to modulate the biointerface reduces the toxic effects of  
graphene while preserving the reinforcement characteristics for application in tissue 
engineering scaffolds, and has enormous interest for polymer/graphene biomaterials 
development [71].
There are no published studies of  in vivo biocompatibility of  novel silver/poly(vinyl 
alcohol)/graphene and silver/poly(vinyl alcohol)/chitosan/graphene hydrogels aimed 
for medical applications. In this paper, we have shown for the fi rst time the soft 
tissue response of  novel silver–doped/PVA/Gr and PVA/CHI/Gr nanocomposite 
hydrogels aimed for medical applications. These novel hydrogels were produced by 
in situ electrochemical syntheses of  silver nanoparticles in adequate matrixes as we 
described in our previously published works [30,37−39]. The results of  our present 
study show that each of  the TIrI scores, the leukocyte number around the implanted 
materials and capsule thickness were gradually decreased during 60 days follow-up. 
At the end-point of  follow-up, Ag/PVA/CHI/Gr implant was surrounded with a 
thinner capsule, while both the TIrI scores and number of  leukocytes of  the peri-
implant zone were greater compared to Ag/PVA/Gr implant, similar to the results of  
other investigations of  porous PVA/chitosan hydrogels [67] or PVA/graphene oxide/
starch/Ag polymer nanocomposite fi lms [43]. Despite the observed differences, we 
can conclude that our in vivo experiment suggested that both novel hydrogels were 
biocompatible and potentially suitable for medical use.
CONCLUSION
The results of  histological analyses of  in vivo soft tissue applications of  Ag/PVA/
Gr and Ag/PVA/CHI/Gr hydrogel implants in rats indicated a satisfactory tissue 
response to these novel polymers. Together with our previous studies of  their synthesis, 
and mechanical, thermal and biological in vitro properties, our present study indicated 
that both Ag/PVA/Gr and Ag/PVA/CHI/Gr are promising biomaterials for use in 
human and veterinary medicine.
Acknowledgments
This study was supported by Ministry of  Education, Science and Technological 
Development of  Republic of  Serbia grant projects III 45019 and OI 175064, and 
Acta Veterinaria-Beograd 2018, 68 (3), 321-339
334
Basic Science Research Program through the National research Foundation of  Korea 
– Ministry of  Education, Science and Technology grand project 2016R1A2B4016034.
Authors’ contributions
TLB and VT were participated in the study design, performed the experimental 
work, an analyzed the data, and drafted the manuscript. VMS, KN and KYR carried 
otu the novel hydrogels synthesis, as well as supervised and facilitated in the overall 
write-up. DM, BBP, IM and ND participated in the study design and performed the 
experimental work, IM helped in prepared fi gures. All authors read and approved the 
fi nal manuscript.
Declaration of  confl icting interests
The author(s) declared no potential confl icts of  interest with respect to the research, 
authorship, and/or publication of  this article.
REFERENCES
1. vonRecum AF: Hand book of  biomaterials evaluation: scientifi c, technical and clinical testing of  implant 
materials. 2nd ed. London, UK: Taylor & Francis; 1999.
2. Kumar A, Jaiswal M: Design and in vitro investigation of  nanocomposite hydrogel based 
in situ spray dressing for chronic wounds and synthesis of  silver nanoparticles using green 
chemistry. J Appl Polym Sci 2016, 133:1–14. 
3. Zhang D, Zhou W, Wei B, Wang X, Tang R, Nie J, Wang J: Carboxyl-modifi ed poly (vinyl 
alcohol)-crosslinked chitosan hydrogel fi lms for potential wound dressing. Carbohyd Polym 
2015, 125:189−199.
4. Baker MI, Walsh SP, Schwartz Z, Boyan BD: A review of  polyvinyl alcohol and its uses in 
cartilage and orthopedic applications. J Biomed Mater Res - Part B Appl Biomater 2012, 
100 B:1451–1457. 
5. Kanimozhi K, Basha SK, Kumari VS: Processing and characterization of  chitosan/PVA 
and methylcellulose porous scaffolds for tissue engineering. Mater Sci Eng C 2016, 61:484–
491. 
6. Oh SH, An DB, Kim TH, Lee JH: Wide-range stiffness gradient PVA/HA hydrogel to 
investigate stem cell differentiation behavior. Acta Biomater 2016, 35:23–31. 
7. Koehler J, Brandl FP, Goepferich AM: Hydrogel wound dressings for bioactive treatment 
of  acute and chronic wounds. Eur Polym J 2018, 100:1–11. 
8. Schmedlen RH, Masters KS, West JL: Photocrosslinkable polyvinyl alcohol hydrogels that 
can be modifi ed with cell adhesion peptides for use in tissue engineering. Biomaterials 
2002, 23:4325–4332. 
9. Jiang S, Liu S, Feng W: PVA hydrogel properties for biomedical application. J Mech Behav 
Biomed Mater 2011, 4:1228–1233.
Lužajić Božinovski et al.: In vivo investigation of  soft tissue response of  novel silver/poly(vinyl alcohol)/ graphene and silver/poly(vinyl alcohol)/chitosan/graphene hydrogels aimed for medical applications – the fi rst experience
335
10. Peppas NA, Huang Y, Tores-Lugo M, Ward JH, Zhang J: Physicochemical Foundations 
and Structural Design of  Hydrogels in Medicine and Biology. Annu Rev Biomed Eng 2000, 
2:9–29. 
11. Puspitasari T, Raja KML, Pangerteni DS, Patriati A, Putra EGR: Structural Organization of  
Poly(vinyl alcohol) Hydrogels Obtained by Freezing/Thawing and Γ-Irradiation Processes: 
A Small-Angle Neutron Scattering ({SANS}) Study. Procedia Chem 2012, 4:186–193.
12. Cheung RCF, Ng TB, Wong JH, Chan WY: Chitosan: An update on potential biomedical 
and pharmaceutical applications. Mar Drugs 2015, 13:5156–5186. 
13. Kumar MNVR, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ: Chitosan chemistry 
and pharmaceutical perspectives. Chem Rev 2004, 104:6017–6084. 
14. Jayakumar R, Prabaharan M, Kumar PS, Nair SV, Tamura H: Biomaterials based on chitin 
and chitosan in wound dressing applications. Biotechnol Adv 2011, 29:322–337. 
15. Mi FL, Wu YB, Shyu SS, Schoung JY, Huang YB, Tsai YH, Hao JY: Control of  wound 
infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J 
Biomed Mater Res 2002, 59:438–449. 
16. Mi FL, Shyu SS, Wu YB, Lee ST, Shyong JY, Huang RN. Fabrication and characterization 
of  a sponge-like asymmetric chitosan membrane as a wound dressing. Biomaterials 2001, 
22:165–173.
17. Lu S, Gao W, Gu HY: Construction, application and biosafety of  silver nanocrystalline 
chitosan wound dressing. Burns 2008, 34:623–628. 
18. Madihally SV, Matthew HWT: Porous chitosan scaffolds for tissue engineering. Biomaterials 
1999, 20:1133–1142. 
19. Khor E, Lim LY: Implantable applications of  chitin and chitosan. Biomaterials 2003, 
24:2339–2349. 
20. Mishra SK, Ferreira JMF, Kannan S: Mechanically stable antimicrobial chitosan-PVA-silver 
nanocomposite coatings deposited on titanium implants. Carbohydr Polym 2015, 121:37–
48. 
21. Pishbin F, Simchi A, Ryan MP, Boccaccini AR: Electrophoretic deposition of  chitosan/45S5 
Bioglass composite coatings for orthopaedic applications. Surf  Coatings Technol 2011, 
205:5260–5268. 
22. Venkatesan J, Kim SK: Chitosan composites for bone tissue engineering - An overview. 
Mar Drugs 2010, 8:2252–2266. 
23. Felt O, Buri P, Gurny R: Chitosan: A unique polysaccharide for drug delivery. Drug Dev 
Ind Pharm 1998, 24:979–993. 
24. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM: Recent advances on chitosan-based 
micro- and nanoparticles in drug delivery. J Control Release 2004, 100:5–28. 
25. Bhattarai N, Gunn J, Zhang M: Chitosan-based hydrogels for controlled, localized drug 
delivery. Adv Drug Deliv Rev 2010, 62:83–99. 
26. Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E, Domann E, Schnettler 
R: An in vitro assessment of  the antibacterial properties and cytotoxicity of  nanoparticulate 
silver bone cement. Biomaterials 2004, 25:4383–4391. 
27. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PKH, Chiu JF, Che CM: Silver 
nanoparticles : partial oxidation and antibacterial activities. J Biol Inorg Chem 2007, 
12:527–534. 
28. Chou KS, Ren CY: Synthesis of  nanosized silver particles by chemical reduction method. 
Mater Chem Phys 2000, 64:241–246. 
Acta Veterinaria-Beograd 2018, 68 (3), 321-339
336
29. Nešović K, Kojić V, Rhee KY, Mišković-Stanković V: Electrochemical synthesis and 
characterization of  silver doped poly(vinyl alcohol)/chitosan hydrogels. Corrosion 2017, 
73:1437–1447.
30. Twu YK, Chen YW, Shih CM: Preparation of  silver nanoparticles using chitosan 
suspensions. Powder Technol 2008, 185:251–257. 
31. Balandin AA, Ghosh S, Bao W, Calizo I, Teweldebrhan D, Miao F, Lau CN: Superior 
Thermal Conductivity of  Single-Layer Graphene 2008. Nano Lett 2008, 8:902–907. 
32. Weiss NO, Zhou H, Liao L, Liu Y, Jiang S, Huang Y, Duan X: Graphene: An emerging 
electronic material. Adv Mater 2012, 24:5782–5825. 
33. Surudžić R, Janković A, Mitrić M, Matić I, Juranić ZD, Živković Lj, Mišković-Stanković 
V, Rhee KY, Park SJ, Hui D: The effect of  graphene loading on mechanical, thermal and 
biological properties of  poly(vinyl alcohol)/graphene nanocomposites. J Ind Eng Chem 
2016, 34:250–257. 
34. Yang JM, Wang SA: Preparation of  graphene-based poly(vinyl alcohol)/chitosan 
nanocomposites membrane for alkaline solid electrolytes membrane. J Memb Sci 2015, 
477:49–57. 
35. Wang T, Li Y, Geng S, Zhou C, Jia X, Yang F, Zhang L, Ren X, Yang H: Preparation 
of  fl exible reduced graphene oxide/poly(vinyl alcohol) fi lm with superior microwave 
absorption properties. RSC Adv 2015, 5:88958–88964. 
36. Hegab HM, Elmekawy A, Zou L, Mulcahy D, Saint CP, Ginić-Marković M: The controversial 
antibacterial activity of  graphene-based materials. Carbon 2016, 105:362–376. 
37. Abudabbus MM, Jevremović I, Janković A, Perić-Grujić A, Matić I, Vukašinović-Sekulić 
M, Hui, D, Rhee, KY, Mišković-Stanković, V: Biological activity of  electrochemically 
synthesized silver doped polyvinyl alcohol/graphene composite hydrogel discs for 
biomedical applications. Compos Part B Eng 2016, 104:26−34. 
38. Abudabbus MM, Jevremović I, Nešović K, Perić-Grujić A, Rhee KY, Mišković-Stanković V: 
In situ electrochemical synthesis of  silver-doped poly(vinyl alcohol)/graphene composite 
hydrogels and their physico-chemical and thermal properties. Compos Part B Eng 2018, 
140:99−107. 
39. Nešović K, Abudabbus MM, Rhee KY, Mišković-Stanković V: Graphene Based Composite 
Hydrogel for Biomedical Applications. Croat Chem Acta 2017, 90:207−213.
40. Wang J, Wang X, Xu C, Zhang M, Shang X: Preparation of  graphene/poly(vinyl alcohol) 
nanocomposites with enhanced mechanical properties and water resistance. PolymInt 
2011, 60:816–822.
41. Xue R, Xin X, Wang L, Shen J, Ji F, Li W, Jia C, Xu G: A systematic study of  the effect of  
molecular weights of  polyvinyl alcohol on polyvinyl alcohol-graphene oxide composite 
hydrogels. PhysChemChemPhys 2015, 17:5431–5440.
42. Abudabbus MM, Jevremović I, Janković A, Perić-Grujić A, Matić I, Vukašinović-Sekulić 
M, Hui D, Rhee K.Y, Mišković-Stanković V: Biological activity of  electrochemically 
synthesized silver doped polyvinyl alcohol/graphene composite hydrogel discs for 
biomedical applications. Compos Part B Eng 2016, 104:26–34.
43. Usman A, Hussain Z, Riaz A, Khan AN: Enhanced mechanical, thermal and antimicrobial 
properties of  poly(vinyl alcohol)/graphene oxide/starch/silver nanocomposites fi lms. 
CarbohydrPolym 2016, 153:592–599.
44. Pandele AM, Ionita M, Crica L, Dinescu S, Costache M, Iovu H: Synthesis, characterization, 
and in vitro studies of  graphene oxide/chitosan-polyvinyl alcohol fi lms. CarbohydrPolym 
2014, 102:813–820.
Lužajić Božinovski et al.: In vivo investigation of  soft tissue response of  novel silver/poly(vinyl alcohol)/ graphene and silver/poly(vinyl alcohol)/chitosan/graphene hydrogels aimed for medical applications – the fi rst experience
337
45. Peppas NA, Bures P, Leobandung W, H Ishikawa: Hydrogels in pharmaceutical formulations. 
Eur J Pharm Biopharm 2000, 50:27−46.
46. Muppalaneni S, Omidian H: Polyvinyl alcohol in medicine and pharmacy: A Perspective. J 
Devel Drugs 2013, 2:1−5
47. Hyon SH, Cha WI, Ikada Y, Kita M, Ogura Y, Honda Y: Poly (vinyl alcohol) hydrogels as 
soft contact lens material. J BiomaterSciPolym Ed 1994, 5:397–406.
48. Jiang H, Zuo Y, Zhang L, Li J, Zhang A, Li Y, Yang X: Property-based design: optimization 
and characterization of  polyvinyl alcohol (PVA) hydrogel and PVA-matrix composite for 
artifi cial cornea. J Mater Sci Mater Med 2014, 25:941–952.
49. Shokrgozar MA, Bonakdar S, Dehghan MM, Emami SH, Montazeri L, Azari S, Rabbani M: 
Biological evaluation of  polyvinyl alcohol hydrogel crosslinked by polyurethane chain for 
cartilage tissue engineering in rabbit model. J Mater Sci Med 2013, 24:2449–2460.
50. Hayes JC, Kennedy JE: An evaluation of  the biocompatibility properties of  a salt-modifi ed 
polyvinyl alcohol hydrogel for a knee meniscus application. Mater SciEng C Mater BiolAppl 
2016, 59:894–900.
51. Kobayashi M, Togushida J, Oka M: Development of  polyvinyl alcohol-hydrogel shields 
with a high water content for tendon injury repair. J Hand Surg Br 2001, 26:436–440.
52. Kobayashi M, Oka M: Composite device for attachment o polyvinyl alcohol-hydrogel to 
underlying bone. Artif  Organs 2004, 28:734–738.
53. Guo Y, Guo J, Bai D, Wang H, Zheng X, Guo W, Tian W: Hemiarthroplasty of  the shoulder 
joint using a custom-designed high-density nano-hydroxyapatite/ polyamide prosthesis 
with a polyvinyl alcohol hydrogel humeral head surface in rabbits. Artif  Organs 2014, 
38:580–586.
54. Deerenberg EB, Mulder IM, Ditzel M, Slieker JC, Bemelman WA, Jeekel J, Lange JF: 
Polyvinyl alcohol hydrogel decreases formation of  adhesions in a rat model of  peritonitis. 
Surg Infect (Larchmt) 2012, 13:321–325.
55. Moretto A, Tesolin L, Marsilio F, Schiavon M, Berna M, Veronese FM: Slow release of  two 
antibiotics of  veterinary interest from PVA hydrogels. Farmaco 2004, 59:1–5.
56. Basak P, Adhikari B: Poly (vinyl alcohol) hydrogels for pH dependent colon targeted drug 
delivery. J Mater Sci Mater Med 2009, 20(Suppl 1):137–146.
57. Kim TH, An DB, Oh SH, Kang MK, Song HH, Lee JH: Creating stiffness gradient 
polyvinyl alcohol hydrogel using a simple gradual freezing-thawing method to investigate 
stem cell differentiation behaviors. Biomaterials 2015, 40:51–60.
58. Li P, Jiang S, Yu Y, Yang J, Yang Z: Biomaterial characteristics and application of  silicone 
rubber and PVA hydrogels mimicked in organ groups for prostate brachytherapy. J 
MechBehav Biomed Mater 2015, 49:220–234.
59. Alexandre N, Amorim I, Caseiro AR, Pereira T, Alvites R, Rêma A, Gonçalves A, Valadares 
G, Costa E, Santos-Silva A, Rodrigues M, Lopes MA, Almeida A, Santos JD, Maurício AC, 
Luís AL: Long term performance evaluation of  small-diameter vascular grafts based on 
polyvinyl alcohol hydrogel and dextran and MSCs-based therapies using the ovine pre-
clinical animal model. Int J Pharm 2017, 523:515–530.
60. Scaretta FV: 5 to 8 years follow-up of  knee chondral defects treated by PVA-H hydrogel 
implants. Eur Rev Med PharmacolSci 2013, 17:3031–3038.
61. Taleb C, Berner S, Mantovani Ruggiero G: First metacarpal resurfacing with polyvinyl 
alcohol implant in osteoarthritis: preliminary study. Chir Main 2014, 33:189–195.
Acta Veterinaria-Beograd 2018, 68 (3), 321-339
338
62. Daniels TR, Younger AS, Penner MJ, Wing KJ, Miniaci-Coxhead SL, Pinsker E, Glazebrook 
M: Midterm outcomes of  polyvinyl alcohol hydrogel hemiarthroplasty of  the fi rst 
metatarso-phalangeal joint in advanced hallux rigidus. Foot Ankle Int 2017, 38:243–247.
63. Baker MI, Walsh SP, Schwartz Z, Boyan BD: A review of  polyvinyl alcohol and its uses 
in cartilage and orthopedic applications. J Biomed Mater Res B ApplBiomater 2012, 
100:1451–1457.
64. Lee JM, Sultan MT, Kim SH, Kumar V, Yeon YK, Lee JH: Artifi cial auricular cartilage using 
silk fi broin and polyvinyl alcohol hydrogel. Int J MolSci 2017, 18:1707.
65. Dashtdar H, Murali MR, Abbas AA, Suhaeb AM, Selvaratnam L, Tay LX, Kamarul T: PVA-
chitosan composite hydrogel versus alginate beads as a potential mesenchymal stem cell 
carrier for the treatment of  focal cartilage defects. Knee Surg Sports TraumatolArthrosc 
2015; 23:1368–1377.
66. Kamoun EA, Kenawy ES, Chen X: A review on polymeric hydrogel membranes for wound 
dressing applications: PVA-based hydrogel dressings. J Adv Res 2017, 8:217–233.
67. Wu JQ, Liu Y, Yang TF, Mu YH, Guo T, Li YB: Porous polyvinyl alcohol hydrogel 
composite prepared and studied initially for biocompatibility. Sichuan Da XueXueBao Yi 
Xue Ban 2007, 38:705–708, 724.
68. Korbekandi H, Iravani S: Silver Nanoparticles. In: The Deliveri of  Nanoparticles. Rijeka, 
Croatia: Intech Open; 2012, 3–36.
69. Pencheva D, Bryaskova R, Kantardjiev T: Polyvinyl alcohol/silver nanoparticles ({PVA/
AgNPs}) as a model for testing the biological activity of  hybrid materials with included 
silver nanoparticles. Mater SciEng C 2012, 32:2048–2051.
70. Fan Z, Liu B, Wang J, Zhang S, Lin Q, Gong P, Ma L, Yang S: A novel wound dressing 
based on Ag/graphene polymer hydrogel: effectively kill bacteria and accelerate wound 
healing. AdvFunct Mater 2014, 24:3933–3943.
71. Linares J, Matesanz MC, Feito MJ, Salavagione HJ, Martínez G, Gómez-Fatou M, Portolés 
MT: Infl uence of  the covalent immobilization of  graphene oxide in poly(vinyl alcohol) on 
human osteoblast response. Colloids Surf  B Biointerfaces 2016, 138:50–59.
72. Shang S, Li J, Zhao Y, Xi Z, Lu Z, Li B, Yang X, Li R: Oxidized graphene-aggravated 
allergic asthma is antagonized by antioxidant vitamin E in Balb/c mice. Environ SciPollut 
Res Int 2017, 24:1784–1793.
Lužajić Božinovski et al.: In vivo investigation of  soft tissue response of  novel silver/poly(vinyl alcohol)/ graphene and silver/poly(vinyl alcohol)/chitosan/graphene hydrogels aimed for medical applications – the fi rst experience
339
ODGOVOR MEKOG TKIVA NA IMPLANTACIJU 
NOVOSINTETISANIH SREBRO/POLIVINIL ALKOHOL/
GRAFEN I SREBRO/POLIVINIL ALKOHOL/HITOZAN/
GRAFEN HIDROGELOVA NAMENJENIH BIOMEDICINSKOJ 
UPOTREBI- PRVO ISKUSTVO
LUŽAJIĆ BOŽINOVSKI Tijana, MARKOVIĆ Danica, TODOROVIĆ Vera, 
PROKIĆ Bolka Bogomir, MILOŠEVIĆ Ivan, DRNDAREVIĆ Neda, NEŠOVIĆ 
Katarina, KYONG Yop Rhee, MIŠKOVIĆ-STANKOVIĆ Vesna
U ovom radu prvi put su prikazani rezultati in vivo ispitivanja rekcije mekog tkiva 
na nove nanokompozitne hidrogelove implantirane u potkožno tkivo pacova, koji 
su predviđeni za medicinsku primenu. Novi nanokompozitni hidrogelovi – srebro/
poli(vinil alkohol)/grafen (Ag/PVA/Gr) i srebro/poli(vinil alkohol)/hitozan/grafen 
(Ag/PVA/CHI/Gr) su proizvedeni in situ elektrohemijskom sintezom nanočestica 
srebra u polimernim matricama, u obliku diskova, kao što je opisano u našim pre-
thodno objavljenim radovima. Ag/PVA/Gr i Ag/PVA/CHI/Gr, kao i kontrolni Ag/
PVA, Ag/PVA/CHI i komercijalni Suprasorb©, implantirani su u potkožno tkivo pa-
cova. Posle 7, 15, 30 i 60. dana od implantacije, izdvajani su implantati s okolnim 
tkivom, a zatim obrađeni za histološki pregled. Ispitivani su indeks iritacije tkiva (TIrI) 
prema ISO 10993-6, 2007, kao i broj leukocita u zoni neposredno oko implantata i 
debljina vezivnotkivne kapsule. Rezultati pokazuju da su se TIrI, broj leukocita oko 
implantiranih materijala i debljina kapsule postepeno smanjivali tokom perioda pro-
matranja. Na kraju eksperimentalnog perioda, implantat od Ag/PVA/CHI/Gr imao 
je veću vrednost TIrI i veći broj leukocita u peri-implantnoj zoni, ali je bio okružen 
tanjom kapsulom, u poređenju sa implantatom od Ag/PVA/Gr. Međutim, i pored 
ovih razlika, možemo zaključiti da rezultati našeg in vivo eksperimenta sugerišu da su 
novi hidrogelovi biokompatibilni i prikladni za medicinsku upotrebu.
